Market Access, Pricing & Commercialization

Strategic life science consulting

Access doesn’t begin at approval.
It begins at your trial design.

We partner with pharma and biotech companies to accelerate time to value – bringing senior, real-world expertise to every commercial decision.

Pre-Launch
Launch
Post-Launch
Cross-functional excellence

Senior advisors.
Real-world experience.
Faster results.

+
Combined years of pharma
& biotech experience
Products launched globally
+
Experience working in over
30 countries

Full Product Lifecycle

Our approach spans the full product lifecycle. Whether you’re preparing for launch, navigating complex payer negotiations, or defending a mature asset, we provide the strategic clarity that drives early and sustained market adoption.

A Wealth of Experience

We combine commercial rigour with practical, on-the-ground experience that other firms simply cannot offer.

Most Pharma Companies Execute Market Access and commercialization Plans Late in the Launch Sequence.

Sensa works differently. Our team of global experts build evidence strategies, pricing architecture, and commercial plans that seamlessly connect from early phase and throughout lifecycle management, making your therapy successfully available for patients who need it.

Who we work with

We work with pharmaceutical companies, biotech startups and life science investors globally, where our expertise can have the most meaningful impact, and commercialization decisions carry the highest stakes.

Our focus is on complex markets, from pre-commercial biotech to specialty, rare disease, oncology, and cell and gene therapy.

The strategy is only as strong as the organization built to execute it

Cross-functional launch governance
Shared evidence & value narrative
Integrated planning processes
Launch readiness assessment
Capability building & team design
Performance & accountability systems

Commercial strategy across the product lifecycle

We support life sciences teams from early market planning through launch execution and post-launch growth, helping products move through each stage with clearer strategy, stronger evidence, and better commercial readiness.

Stage 01

Pre-Launch

Before launch, we help teams understand the opportunity, pressure-test assumptions, and define the commercial choices that will shape market entry.

Stage 02

Launch

At launch, we help turn planning into coordinated execution, ensuring the product, team, and market approach are aligned around the decisions that matter most.

Stage 03

Post-Launch

After launch, we help teams respond to market signals, strengthen performance, and identify the next opportunities to expand or defend value.

AI-enabled decision intelligence

Data-backed decisions at every inflection point

Launch, access, and evidence decisions are increasingly complex, and the cost of getting them wrong is rising. We use AI-powered analytics to help life sciences teams see what the data is signaling earlier, model likely payer and market responses, and act with greater confidence at each critical decision point.

48%

of pharma execs allocating >25% of budget to AI in 2025

22%

of life sciences leaders have successfully scaled AI – creating the advisory gap we close

Ready to start?

Whether you’re preparing for launch or rethinking your commercial strategy, our team is ready to help.

202-555-0188
Scroll to Top